Skip to main content
Ronald Paquette, MD, Oncology, Los Angeles, CA

Ronald Leo Paquette MD


Professor, Medicine, UCLA School of Medicine

Join to View Full Profile
  • 8700 Beverly Blvd.AC1070Los Angeles, CA 90095

  • Phone+1 310-423-1160

  • Fax+1 310-659-8045

Dr. Paquette is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1987 - 1990
  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1984 - 1987
  • Ohio State University College of Medicine
    Ohio State University College of MedicineClass of 1984

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1987 - 2026
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Phase 1 Dose Escalation and Expansion Study to Determine Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the BET Inhibitor FT-1101 As a Single Agent in...
    Ronald Paquette, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

  • Cedars-Sinai Again Earns Top Ranking for Blood and Marrow Transplants
    Cedars-Sinai Again Earns Top Ranking for Blood and Marrow TransplantsFebruary 6th, 2025
  • Cedars-Sinai’s Stem Cell and Bone Marrow Transplant Program Recognized with Two Major Hallmarks of Quality
    Cedars-Sinai’s Stem Cell and Bone Marrow Transplant Program Recognized with Two Major Hallmarks of QualityJanuary 18th, 2023
  • Hitting Stem Cell and CAR T Targets
    Hitting Stem Cell and CAR T TargetsJanuary 17th, 2023
  • Join now to see all

Grant Support

  • Phase I Study Of Recombinant Human Hemoglobin (Rhb1.1) In Patients W/AnemiaNational Center For Research Resources1999–2001
  • Phase I/II Trial Of Recombinant Methionyl Human Stem Cell FactorNational Center For Research Resources1995–1999
  • Phase I Study Of Recombinant Human Hemoglobin (Rhb1.1) In Patients W/Anemia ASSNational Center For Research Resources1998
  • Myeloid Specific Regulation Of IGG FC Receptor Type INational Heart, Lung, And Blood Institute1994–1997
  • Myeloid-Specific Regulation Of IGG FC Receptor Type INational Heart, Lung, And Blood Institute1993

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: